Company intelligence / Profile preview
Xi'an Beilin Pharmaceutical
Xi'an, Shaanxi, China
- Ownership
- Private
- Employees
- ~1000
- Development stage
- Other
01
Overview
Xi'an Beilin Pharmaceutical commercializes leading traditional Chinese medicines in ophthalmology and throat, with several branded and patented products and ongoing clinical development, including a new tablet for hypertrophic retinopathy
- Therapeutic areas
- Infectious DiseasesOphthalmology
- Modalities
- Herbal medicineSmall molecule
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
111, Inc.—strategic partnership for digital development and distribution of Chinese patent medicinesDuoputai Pharmaceutical (strategic investment/associate in cardiovascular)
Beyond the preview
Go deeper on Xi'an Beilin Pharmaceutical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Xi'an Beilin Pharmaceutical.